Stem Cell Therapy for Epidermolysis Bullosa—Does It Work?
Authors:
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (11) , 2119-2121
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis BullosaJournal of Investigative Dermatology, 2016
- Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trialDermatologic Therapy, 2015
- Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis BullosaThe Journal of Pediatrics, 2015
- Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα+ mesenchymal cells from bone marrowScientific Reports, 2015
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classificationJournal of the American Academy of Dermatology, 2014
- Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosaCytotherapy, 2010
- Bone Marrow Cell Transfer into Fetal Circulation Can Ameliorate Genetic Skin Diseases by Providing Fibroblasts to the Skin and Inducing Immune ToleranceThe American Journal of Pathology, 2008
- Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantationBlood, 2008
- Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfectaBlood, 2001
- Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfectaNature Medicine, 1999